Walleye Trading’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.5M | Sell |
51,904
-16,346
| -24% | -$1.09M | ﹤0.01% | 1515 |
|
|
2026
Q1 | $4.29M | Sell |
68,250
-115,151
| -63% | -$8.02M | 0.01% | 1224 |
|
|
2025
Q4 | $12.2M | Buy |
183,401
+100,650
| +122% | +$6.51M | 0.02% | 828 |
|
|
2025
Q3 | $5.57M | Buy |
82,751
+57,132
| +223% | +$4.52M | 0.01% | 1206 |
|
|
2025
Q2 | $2.24M | Sell |
25,619
-17,382
| -40% | -$1.36M | ﹤0.01% | 1665 |
|
|
2025
Q1 | $2.94M | Buy |
43,001
+11,904
| +38% | +$971K | 0.01% | 1396 |
|
|
2024
Q4 | $2.42M | Buy |
+31,097
| New | +$2.3M | 0.01% | 1572 |
|
|
2024
Q3 | – | Sell |
-56,466
| Closed | -$4.64M | – | 4205 |
|
|
2024
Q2 | $6.4M | Buy |
56,466
+31,563
| +127% | +$3.99M | 0.02% | 929 |
|
|
2024
Q1 | $3.45M | Sell |
24,903
-32,519
| -57% | -$4.09M | 0.01% | 1374 |
|
|
2023
Q4 | $7.13M | Buy |
57,422
+38,283
| +200% | +$3.91M | 0.02% | 999 |
|
|
2023
Q3 | $1.79M | Buy |
+19,139
| New | +$2.16M | ﹤0.01% | 1870 |
|
|
2022
Q3 | – | Sell |
-18,885
| Closed | -$1.6M | – | 5132 |
|
|
2022
Q2 | $1.41M | Buy |
+18,885
| New | +$1.72M | ﹤0.01% | 1950 |
|
|
2021
Q3 | – | Sell |
-1,696
| Closed | -$214K | – | 5309 |
|
|
2021
Q2 | $181K | Sell |
1,696
-5,212
| -75% | -$501K | ﹤0.01% | 4000 |
|
|
2021
Q1 | $621K | Sell |
6,908
-23,392
| -77% | -$2.2M | ﹤0.01% | 2404 |
|
|
2020
Q4 | $2.8M | Buy |
+30,300
| New | +$2.71M | 0.01% | 1140 |
|
|
2020
Q2 | – | Sell |
-24,060
| Closed | -$2.15M | – | 4303 |
|
|
2020
Q1 | $1.62M | Buy |
+24,060
| New | +$1.5M | 0.01% | 981 |
|
|
2019
Q2 | – | Sell |
-21,188
| Closed | -$666K | – | 4130 |
|
|
2019
Q1 | $631K | Buy |
+21,188
| New | +$745K | ﹤0.01% | 2061 |
|
|
2018
Q4 | – | Sell |
-26,824
| Closed | -$851K | – | 4782 |
|
|
2018
Q3 | $959K | Buy |
+26,824
| New | +$832K | 0.01% | 2115 |
|
|
2018
Q1 | – | Sell |
-46,968
| Closed | -$695K | – | 4529 |
|
|
2017
Q4 | $674K | Sell |
46,968
-33,728
| -42% | -$438K | ﹤0.01% | 2325 |
|
|
2017
Q3 | $987K | Buy |
80,696
+60,456
| +299% | +$1.07M | ﹤0.01% | 1889 |
|
|
2017
Q2 | $370K | Buy |
20,240
+17,816
| +735% | +$329K | ﹤0.01% | 2642 |
|
|
2017
Q1 | $51K | Buy |
2,424
+1,452
| +149% | +$28.3K | ﹤0.01% | 3764 |
|
|
2016
Q4 | $15K | Buy |
+972
| New | +$17.2K | ﹤0.01% | 4178 |
|
|
2016
Q1 | – | Sell |
-8,896
| Closed | -$182K | – | 5420 |
|
|
2015
Q4 | $182K | Buy |
+8,896
| New | +$185K | ﹤0.01% | 2784 |
|
Other funds holding DXCM
Walleye Trading's DXCM Position: Q2 2026 in Review
Walleye Trading reduced its DexCom (DXCM) stake by 24% in Q2 2026, selling an estimated $1.09M and leaving 51,904 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1515.
Walleye Trading first reported a position in DXCM in Q4 2015 and has held it in 24 quarters since. The position peaked at $12.2M in Q4 2025. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Walleye Trading held 51,904 shares of DexCom worth $3.5M as of Q2 2026.
- Walleye Trading sold 16,346 DexCom shares in Q2 2026, an estimated $1.09M.
- DexCom made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #1515 holding.
- Walleye Trading first reported a position in DexCom in Q4 2015 and has held it in 24 quarters since.
- Walleye Trading's DexCom position peaked at $12.2M in Q4 2025.
- 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.